Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Área temáticas
Medicina y salud(3)
Cirugía y especialidades médicas afines(2)
Enfermedades(2)
Farmacología y terapéutica(2)
Área de conocimiento
Neurología(3)
Origen
scopus(3)
Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America
ArticleAbstract: Background; Optic neuritis (ON) can be an initial manifestation of neuromyelitis optica spectrum disPalabras claves:Autores:Alonso R., Bribiesca Contreras E., Caride A., Casas M., Cohen L., Contentti E.C., Criniti J.M., Cristiano E., Daccach Marques V., Edgar Patricio Correa, Flores-Rivera J., Galleguillos L., Gómez-Figueroa E., Jefferson Santiago Piedra-Andrade, Lana-Peixoto M.A., López P.A., María Angélica Ortiz-Yépez, Nadur D., Patrucco L., Pettinicchi J.P., Rojas J.I., Soto de Castillo I., Tkachuk V., Toral-Granda A.M., Wilson Alfredo Gualotuña PachacamaFuentes:scopusAcute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study
ArticleAbstract: Background: Few studies regarding MRI-defined acute optic nerve lesions (aONL) in patients with firsPalabras claves:Latin America population, neuromyelitis optica spectrum disorders, optic neuritis, optic neuritis lesions, conventional MRI, visual prognosisAutores:Caride A., Castillo M.C., Contentti E.C., Criniti J.M., Cristiano E., Daccach Marques V., Delgado-García G., dos Santos A.C., Edgar Patricio Correa, Flores-Rivera J., Gómez-Figueroa E., López P.A., Marcelo Oswaldo Álvarez Pucha, Miño-Zambrano J.E., Patrucco L., Pettinicchi J.P., Rivas-Alonso V., Rojas J.I., Serva Braga Diéguez G., Soto de Castillo I., Tkachuk V.Fuentes:scopusTherapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America
ArticleAbstract: Purpose: This study describes the therapeutic strategies in NMOSD and MOGAD adopted by neurologistsPalabras claves:Latin America, MOGAD, NMOSD, rituximab, STRATEGIES, TherapeuticAutores:Alonso R., Becker J., Bribiesca Contreras E., Caride A., Castillo I.S.d., Contentti E.C., Criniti J.M., Cristiano E., Daccach Marques V., Edgar Patricio Correa, Flores-Rivera J., Galleguillos L., Gómez-Figueroa E., Gracia F., Hamuy F.D.d.B., Jefferson Santiago Piedra-Andrade, Lana-Peixoto M.A., López P.A., Man F., María Angélica Ortiz-Yépez, Nadur D., Navas C., Patrucco L., Pettinicchi J.P., Rojas J.I., Soares Neto H.R., Tkachuk V., Toral-Granda A.M., Wilson Alfredo Gualotuña PachacamaFuentes:scopus